L'Eau Tech is currently developing two nasal devices: The Airwave is a novel nasal dilator designed to optimize nasal breathing during exercise, sleep and periods of nasal congestion. The Rhinostat is an internal nosebleed clasp with biomaterial interface designed to stop most nosebleeds, prevent expensive and irritating interventions and promote healing of nasal mucosae. Provisional patenting has been obtained for the Rhinostat. L'Eau Tech is also collaborating with a team of UW-based scientists and clinicians to develop the Moment5 protective barrier enclosure device. This is a negative-pressure mobile shield that contains COVID-suspect, COVID-positive or other contagious patients and protects their healthcare providers during transport through the healthcare system.
| Employees | 1 (0 on RocketReach) |
| Founded | 2018 |
| Industry | Medical Devices |
Looking for a particular L'Eau Tech employee's phone or email?
L'Eau Tech Questions
Related Companies
